Treatment of Carotid Sinus Hypersensitivity Syndrome

Initial Assessment and Treatment

The American College of Cardiology recommends permanent dual-chamber cardiac pacing as the treatment of choice for carotid sinus hypersensitivity syndrome when a cardioinhibitory response (asystole >3 seconds) is documented and associated with recurrent syncope 1, 2, 3
Initial assessment should determine the reflex components, including cardioinhibitory, vasodepressor, or mixed response, to guide treatment 1, 4
A cardioinhibitory response is defined as asystole >3 seconds due to sinus arrest or AV block during carotid sinus massage, while a vasodepressor response is a systolic blood pressure drop ≥50 mmHg independent of heart rate changes 1, 4
The American College of Cardiology notes that approximately 10-20% of patients have a significant vasodepressor component that will not respond to pacing alone, emphasizing the importance of defining this component before pacing 1, 4

For cardioinhibitory or predominantly cardioinhibitory response, the American College of Cardiology indicates permanent dual-chamber pacing (Class I recommendation) for recurrent syncope caused by spontaneously occurring carotid sinus stimulation that induces ventricular asystole >3 seconds 1, 3, 5
Dual-chamber pacing is preferred over single-chamber ventricular pacing because it maintains AV synchrony and may help address any vasodepressor component 2, 5
Pacing is effective in relieving symptoms in patients with excessive cardioinhibitory response, with evidence showing that pacemaker therapy reduced syncope recurrence from 57-60% in untreated patients to 5-9% in paced patients over follow-up periods of 1-3.7 years 2, 5

The American College of Cardiology suggests considering carotid sinus hypersensitivity in elderly patients with unexplained falls, even without documented loss of consciousness, and notes that pacing can significantly reduce the likelihood of subsequent falls in this population 1, 4
For asymptomatic carotid sinus hypersensitivity, pacing is contraindicated (Class III), as asymptomatic spontaneous or provoked prolonged sinus pauses have an excellent prognosis without pacing 5, 6, 7

The European Heart Journal recommends discontinuing or reducing chronic vasodilator therapy when possible, as these drugs enhance susceptibility to carotid sinus syndrome 2
Medical therapy with anticholinergic drugs has been largely abandoned due to poor efficacy 2